This provides an extra buffer to ensure maximum absorption has occurred without any interference
Please be sure to complete this at your earliest convenience to avoid any delays in your treatment plan
With up to 28.7% mean weight loss and up to 71.2 pounds average weight reduction at the highest dose, retatrutide delivered the most impressive weight loss results of any obesity medication studied to date, and injection site complications remained minimal throughout
Blood glucose, food intake, and major tissues including brown adipose, liver, and spleen weights were similar between RETA and SEMA, yet RETA uniquely reduced adiposity and delayed tumor latency suggesting that targeting a single receptor GLP1R was effective for many physiologic and metabolic benefits, but the additional agonism of GIPR and GPCR by RETA uniquely impacted adiposity, tumor onset, and tumor progression
Results vary.
Choose your site based on the rotation schedule